一种含屈螺酮的新型口服避孕药的安全性和有效性。
Safety and efficacy of a new oral contraceptive containing drospirenone.
作者信息
Shulman Lee P
机构信息
Division of Reproductive Genetics, Department of Obstetrics and Gynecology, University of Illinois at Chicago, 820 South Wood Street, M/C 808, Chicago, IL 60612-7313, USA.
出版信息
J Reprod Med. 2002 Nov;47(11 Suppl):981-4.
An oral contraceptive containing ethinyl estradiol and the unique progestin drospirenone provides a new contraceptive option. Ethinyl estradiol is the form of synthetic estrogen used in most oral contraceptives. Drospirenone differs from other synthetic progestins in that it is derived from 17 alpha-spirolactone and is an analogue of spironolactone. The oral contraceptive containing ethinyl estradiol and the unique progestin drospirenone has been shown to be highly efficacious and to provide safety equivalent to that of other oral contraceptive formulations.
一种含有炔雌醇和独特孕激素屈螺酮的口服避孕药提供了一种新的避孕选择。炔雌醇是大多数口服避孕药中使用的合成雌激素形式。屈螺酮与其他合成孕激素不同，它源自17α-螺内酯，是螺内酯的类似物。含有炔雌醇和独特孕激素屈螺酮的口服避孕药已被证明具有高效性，且安全性与其他口服避孕药配方相当。
Zotero 插件